Memorial Sloan-Kettering Cancer Center
Basking Ridge, New Jersey 10065
1 studies enrolling now · 36 studies all time
What they study most
Acute Myelogenous Leukemia, Adenoid Cystic Carcinoma, Atrophic Vaginitis, Bladder Cancer, Brain Cancer, Breast Cancer, CD34 Selected Peripheral Blood Stem Cell Graft, CNS BRAIN, CNS Cancer, Cancer, Cholangiocellular Carcinoma, Cholangiolar Carcinoma
Studies at this site
- Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments — Recruiting now
- Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors — Running, not enrolling
- Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer — Running, not enrolling
- Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) — Running, not enrolling
- Lenalidomide Maintenance in Plasma Cell Myeloma — Running, not enrolling
- A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma — Completed
- Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma — Running, not enrolling
- A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers — Running, not enrolling
- Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) — Completed
- Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma — Running, not enrolling
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver — Running, not enrolling
- Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies — Completed
- Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary — Running, not enrolling
- A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. — Running, not enrolling
- Determinants of Bladder Cancer Recurrence Study (The DETER Study) — Running, not enrolling
- Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype — Running, not enrolling
- Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma — Completed
- Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer — Running, not enrolling
- MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study — Running, not enrolling
- Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen — Completed
- High Dose Carfilzomib for Newly Diagnosed Myeloma — Completed
- A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma — Completed
- Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma — Completed
- Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma — Completed
- Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer — Completed
- Breast MRI as a Preoperative Tool for DCIS — Completed
- Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers — Completed
- Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study — Completed
- Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material — Completed
- Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma — Completed
- Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer — Completed
- Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy. — Completed
- A Study to Assess Thymic Function Using PET/CT and MRI — Completed
- Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) — Completed
- Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma — Completed
- Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial — Completed